货号:A126121
同义名:
左氧氟沙星半水合物
/ Levofloxacin hemihydrate; Levaquin hydrate
Levofloxacin hydrate是一种抗生素,针对革兰氏阴性菌,通过抑制细菌 DNA 回旋酶的超螺旋活性来阻止 DNA 复制。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 靶点 |
|
| 描述 | Levofloxacin (Hemihydrate) is a fluoroquinolone antibiotic and is the optical S-(-) isomer of the racemic drug substance ofloxacin. It has a broad spectrum of in vitro activity against Gram-positive and Gram-negative bacteria, as well as certain other pathogens such as Mycoplasma, Chlamydia, Legionella and Mycobacteria spp. Plasma concentrations in healthy volunteers reach a mean peak drug plasma concentration (Cmax) of approximately 2.8 and 5.2 mg/L within 1 to 2 hours after oral administration of levofloxacin 250 and 500 mg tablets, respectively[3]. In stable COPD (chronic obstructive pulmonary disease), levofloxacin treatment causes a short-term reduction in bacterial load[4]. Levofloxacin was found to significantly improve the clinical and microbiological parameters in CP (chronic periodontitis) individuals[5]. A 30-day course of levofloxacin does not significantly improve BK viral load reduction or allograft function when used in addition to overall reduction of immunosuppression[6]. |
| Concentration | Treated Time | Description | References | |
| ZF4 cells | 1 × 10^6 CFU/ml | 3 hours | To test the effect of Lev-S and Lev-R V. alginolyticus on promoter activity in ZF4 cells | Microb Biotechnol. 2020 Jul;13(4):1213-1227. |
| Mycobacterium tuberculosis H37Ra (extracellular) | 0.125 mg/L (1xMIC) | 7 days | To evaluate the bactericidal effect of levofloxacin against extracellular Mycobacterium tuberculosis. Results showed maximal kill (Emax) >7 log10 CFU/mL. | Clin Infect Dis. 2018 Nov 28;67(suppl_3):S293-S302. |
| THP-1 cells | 0.125 mg/L (1xMIC) | 7 days | To evaluate the bactericidal effect of levofloxacin against intracellular Mycobacterium tuberculosis. Results showed that the killing effect was 2 log10 CFU/mL lower than against extracellular bacilli. | Clin Infect Dis. 2018 Nov 28;67(suppl_3):S293-S302. |
| Elizabethkingia anophelis | 0.5 to 128 mg/L | 72 hours | To determine the minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC) of levofloxacin against Elizabethkingia anophelis and investigate its resistance mechanisms | Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0030122. |
| Stenotrophomonas maltophilia K M6 LEVr | 8 μg/ml | Determine the MIC of K M6 LEVr against Levofloxacin | Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01284-20. | |
| Stenotrophomonas maltophilia K M7 | 8 μg/ml | Determine the MIC of K M7 against Levofloxacin | Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01284-20. | |
| Stenotrophomonas maltophilia K M6 | 4 µg/ml | Determine the MIC of K M6 against Levofloxacin | Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01284-20. | |
| Stenotrophomonas maltophilia K279a | 2 µg/ml | Determine the MIC of K279a against Levofloxacin | Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01284-20. |
| Administration | Dosage | Frequency | Description | References | ||
| Zebrafish (Danio rerio) | Zebrafish infection model | Intramuscular injection | 9 × 10^5 CFU/fish | Single injection, observed for 6 days | To evaluate the differences in pathogenicity and immunogenicity between Lev-R and Lev-S V. alginolyticus in zebrafish | Microb Biotechnol. 2020 Jul;13(4):1213-1227. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.35mL 0.27mL 0.14mL |
6.75mL 1.35mL 0.68mL |
13.50mL 2.70mL 1.35mL |
|
| CAS号 | 138199-71-0 |
| 分子式 | C36H42F2N6O9 |
| 分子量 | 740.75 |
| SMILES Code | O=C(C(C1=O)=CN2[C@@H](C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O.[H]O[H].O=C(C(C5=O)=CN6[C@@H](C)COC7=C(N8CCN(C)CC8)C(F)=CC5=C67)O |
| MDL No. | MFCD07772024 |
| 别名 | 左氧氟沙星半水合物 ;Levofloxacin hemihydrate; Levaquin hydrate; Cravit hydrate; Iquix hydrate; Quixin hydrate; Tavanic hydrate |
| 运输 | 蓝冰 |
| InChI Key | SUIQUYDRLGGZOL-RCWTXCDDSA-N |
| Pubchem ID | 3033924 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
| 溶解方案 |
DMSO: 7 mg/mL(9.45 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 50 mg/mL(67.5 mM) 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1